Devyser Diagnostics AB (DVYSF)
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | -- |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -- |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. Its products are used for complex DNA testing in the areas of hereditary diseases, oncology and post-transplantation monitoring. The firm's products are also used in treating cancer patients and in follow-up transplant patients. The company was founded by Anders Hedrum, Ulf Axel Klangby and Dan Hauzenberger in 2004 and is headquartered in Hägersten, Sweden. |
| URL | http://www.devyser.com |
| Investor Relations URL | N/A |
| HQ State/Province | Stockholm |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 20, 2026 |
| Last Earnings Release | Apr. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. Its products are used for complex DNA testing in the areas of hereditary diseases, oncology and post-transplantation monitoring. The firm's products are also used in treating cancer patients and in follow-up transplant patients. The company was founded by Anders Hedrum, Ulf Axel Klangby and Dan Hauzenberger in 2004 and is headquartered in Hägersten, Sweden. |
| URL | http://www.devyser.com |
| Investor Relations URL | N/A |
| HQ State/Province | Stockholm |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 20, 2026 |
| Last Earnings Release | Apr. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |